Submissions for variant NM_001136472.2(LITAF):c.457G>A (p.Ala153Thr)

gnomAD frequency: 0.00003  dbSNP: rs543022814

Total submissions: 3

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Labcorp Genetics (formerly Invitae), Labcorp	RCV000469544	SCV000541545	uncertain significance	Charcot-Marie-Tooth disease type 1C	2021-09-01	criteria provided, single submitter	clinical testing	This sequence change replaces alanine with threonine at codon 153 of the LITAF protein (p.Ala153Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs543022814, ExAC 0.03%). This variant has not been reported in the literature in individuals affected with LITAF-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx	RCV000481674	SCV000574393	uncertain significance	not provided	2017-03-27	criteria provided, single submitter	clinical testing	A variant of uncertain significance has been identified in the LITAF gene. The A153T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The A153T variant is observed in 4/14698 (0.03%) alleles from individuals of South Asian background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The A153T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Illumina Laboratory Services, Illumina	RCV000469544	SCV001274008	uncertain significance	Charcot-Marie-Tooth disease type 1C	2018-01-13	criteria provided, single submitter	clinical testing	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.